S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
The Charles Schwab Company Can Hit New Highs
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
The Charles Schwab Company Can Hit New Highs
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
The Charles Schwab Company Can Hit New Highs
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
The Charles Schwab Company Can Hit New Highs

GlycoMimetics (GLYC) Earnings Date, Estimates & Call Transcripts

$2.26
-0.15 (-6.24%)
(As of 04/15/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

GLYC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GLYC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

GlycoMimetics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.15)($0.14)($0.15)
Q2 20242($0.15)($0.11)($0.13)
Q3 20242($0.19)($0.13)($0.16)
Q4 20242($0.19)($0.14)($0.17)
FY 20248($0.68)($0.52)($0.60)

GLYC Earnings Date and Information

GlycoMimetics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off prior year's report dates.

GlycoMimetics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/1/2024
Estimated)
------- 
11/3/2023Q3 2023($0.14)($0.14)-($0.14)--    
8/2/2023Q2 2023($0.18)($0.13)+$0.05($0.13)--
5/3/2023Q1 2023($0.17)($0.17)-($0.17)--    
3/29/2023Q4 2022($0.17)($0.19)($0.02)($0.19)--
11/9/2022Q3 2022($0.26)($0.16)+$0.10($0.16)--
8/3/2022Q2 2022($0.29)($0.25)+$0.04($0.25)-$0.08 million
4/28/2022Q1 2022($0.31)($0.28)+$0.03($0.28)--    
3/3/2022Q4 2021($0.31)($0.33)($0.02)($0.33)-$0.02 million    
11/2/2021Q3 2021($0.32)($0.34)($0.02)($0.34)-$0.09 million    
8/5/2021Q2 2021($0.31)($0.28)+$0.03($0.28)--  
5/2/2021Q1 2021($0.32)($0.28)+$0.04($0.28)-$1.06 million  

GlycoMimetics Earnings - Frequently Asked Questions

When is GlycoMimetics's earnings date?

GlycoMimetics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off last year's report dates. Learn more on GLYC's earnings history.

How much revenue does GlycoMimetics generate each year?

GlycoMimetics (NASDAQ:GLYC) has a recorded annual revenue of $10,000.00.

How much profit does GlycoMimetics generate each year?

GlycoMimetics (NASDAQ:GLYC) has a recorded net income of -$36.90 million. GLYC has generated -$0.58 earnings per share over the last four quarters.

What is GlycoMimetics's EPS forecast for next year?

GlycoMimetics's earnings are expected to grow from ($0.54) per share to ($0.34) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:GLYC) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners